REGN Deadline Alert: The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. (REGN) Investors of Securities Class Action Deadline on September 14, 2026
The Gross Law Firm issued a solicitation reminding Regeneron Pharmaceuticals investors of the September 14, 2026 deadline to seek lead plaintiff status in a securities class action. The complaint alleges that defendants made misleading statements regarding the Phase III Fianlimab-Libtayo Study, which reportedly failed to reach statistical significance for its primary endpoint.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.